Researchclopedia
Research
Researchers
Institutions
Topics
Submit
About
Search...
⌘
K
Command Palette
Search for a command to run...
Back to research
Pelacarsen and lipoprotein(a) apheresis in secondary prevention: the Lp(a)FRONTIERS APHERESIS trial
2026
1 citations
Journal Article
hybrid Open Access
Field-Weighted Citation Impact:
36.66
·
Tris Pharma (United States)
J Schorr
·
Novartis (Germany)
Philippe Ferber
·
Novartis (Switzerland)
Jing Wang
·
Tris Pharma (United States)
Enrico Cristante
·
Novartis (United Kingdom)
Björn Müller‐Edenborn
·
Novartis (Switzerland)
Anja Vogt
·
LMU Klinikum
Volker Schettler
·
Universitätsmedizin Göttingen
Elisabeth Steinhagen-Thiessen
·
Universitätsmedizin Rostock
Pelacarsen and lipoprotein(a) apheresis in secondary prevention: the Lp(a)FRONTIERS APHERESIS trial | Researchclopedia